<bill session="109" type="h" number="801" updated="2021-09-29T19:52:40Z">
  <state datetime="2005-02-15">REFERRED</state>
  <status>
    <introduced datetime="2005-02-15"/>
  </status>
  <introduced datetime="2005-02-15"/>
  <titles>
    <title type="short" as="introduced">Diabetic Retinopathy Prevention Act of 2005</title>
    <title type="display">Diabetic Retinopathy Prevention Act of 2005</title>
    <title type="official" as="introduced">To amend titles XVIII and XIX of the Social Security Act to provide for coverage under the Medicare and Medicaid Programs of certain screening procedures for diabetic retinopathy, and to amend the Public Health Service Act to establish pilot programs to foster such screening, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C000754"/>
  <cosponsors>
    <cosponsor bioguide_id="B000490" joined="2005-04-05"/>
    <cosponsor bioguide_id="B001236" joined="2005-03-15"/>
    <cosponsor bioguide_id="B001245" joined="2005-05-23"/>
    <cosponsor bioguide_id="B000657" joined="2005-06-16"/>
    <cosponsor bioguide_id="B001227" joined="2005-06-07"/>
    <cosponsor bioguide_id="B001251" joined="2005-04-05"/>
    <cosponsor bioguide_id="C001038" joined="2006-05-19"/>
    <cosponsor bioguide_id="D000599" joined="2005-02-15"/>
    <cosponsor bioguide_id="F000262" joined="2005-02-15"/>
    <cosponsor bioguide_id="G000551" joined="2005-03-15"/>
    <cosponsor bioguide_id="H000067" joined="2005-02-15"/>
    <cosponsor bioguide_id="H000627" joined="2005-05-04"/>
    <cosponsor bioguide_id="J000070" joined="2006-05-19"/>
    <cosponsor bioguide_id="J000284" joined="2005-05-19"/>
    <cosponsor bioguide_id="K000172" joined="2005-04-14"/>
    <cosponsor bioguide_id="L000090" joined="2005-07-25"/>
    <cosponsor bioguide_id="M000309" joined="2005-02-15"/>
    <cosponsor bioguide_id="M001147" joined="2006-05-19"/>
    <cosponsor bioguide_id="M000404" joined="2005-02-15"/>
    <cosponsor bioguide_id="M000590" joined="2005-02-15"/>
    <cosponsor bioguide_id="M000714" joined="2005-02-15"/>
    <cosponsor bioguide_id="O000159" joined="2005-02-15"/>
    <cosponsor bioguide_id="P000149" joined="2005-02-15"/>
    <cosponsor bioguide_id="R000053" joined="2005-02-15"/>
    <cosponsor bioguide_id="S000749" joined="2005-02-15"/>
    <cosponsor bioguide_id="S000810" joined="2005-02-15"/>
    <cosponsor bioguide_id="T000038" joined="2005-02-15"/>
    <cosponsor bioguide_id="T000326" joined="2005-02-15"/>
    <cosponsor bioguide_id="V000128" joined="2006-03-09"/>
    <cosponsor bioguide_id="W000795" joined="2005-02-15"/>
  </cosponsors>
  <actions>
    <action datetime="2005-02-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-02-15" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-02-15">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-02-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2005-02-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Ambulatory care"/>
    <term name="Blood pressure"/>
    <term name="Cholesterol"/>
    <term name="Chronically ill"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost accounting"/>
    <term name="Diabetes"/>
    <term name="Economics and Public Finance"/>
    <term name="Eye care"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to health facilities"/>
    <term name="Finance and Financial Sector"/>
    <term name="Government Operations and Politics"/>
    <term name="Governmental investigations"/>
    <term name="Housing and Community Development"/>
    <term name="Medicaid"/>
    <term name="Medical economics"/>
    <term name="Medical fees"/>
    <term name="Medical screening"/>
    <term name="Medical technology"/>
    <term name="Medical tests"/>
    <term name="Medicare"/>
    <term name="Minorities"/>
    <term name="Minority health"/>
    <term name="Rural health"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
    <term name="Telemedicine"/>
  </subjects>
  <amendments/>
  <summary date="2005-04-15T18:33:21Z" status="Introduced in House">Diabetic Retinopathy Prevention Act of 2005 - Amends Title XVIII (Medicare) and Title XIX (Medicaid) of the Social Security Act to expand Medicare and Medicaid coverage to include remote assessment of diabetic retinopathy (a diagnostic examination that is provided no more than annually to an individual who has been diagnosed with diabetes, that meets technical standards set forth by the Secretary of Health and Human Services, that is furnished via a telecommunications system to an eligible patient, and that is conducted under the supervision of a board-certified ophthalmologist with retinal fellowship training).

Requires the Secretary to study and report to Congress on the costs incurred by health care providers to provide such assessment.

Amends the Public Health Service Act to direct the Secretary to: (1) establish the Mobile Diabetic Retinopathy Screening Pilot Program to make five grants to eligible entities to establish mobile diabetic retinopathy screening programs; (2) give priority to entities with relevant experience who propose to serve rural, impoverished, unserved, minority, and remote populations; and (3) convene an advisory committee to evaluate the Program.</summary>
</bill>
